CIK 0001572616 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
FRACTYL HEALTH, INC.
Sign in to watch- Ticker
- GUTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273553477
- Phone
- 781-902-8800
- Business address
- 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA, 01803
- Former names
- Fractyl Laboratories Inc.
- Open-market buys, last 90 days
- $39,903
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$39,903. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | Caplan Jay David President, Chief Product Off. | Grant or award · Stock Option (right to buy) | +104,400 | 104,400 | ||
| 2025-02-27 | Rajagopalan Harith Chief Executive Officer | Grant or award · Stock Option (right to buy) | +571,491 | 571,491 | ||
| 2025-02-27 | Rajagopalan Harith Chief Executive Officer | Grant or award · Stock Option (right to buy) | +261,540 | 261,540 | ||
| 2025-01-31 | Rajagopalan Harith Chief Executive Officer | Option exercise 10b5-1 | +90,972 | $1.70 | $155K | 582,301 |
| 2025-01-31 | Rajagopalan Harith Chief Executive Officer | Sale 10b5-1 | −90,972 | $1.82 | $165K | 491,329 |
| 2025-01-31 | Rajagopalan Harith Chief Executive Officer | Option exercise · Stock Option 10b5-1 | −90,972 | 11,564 | ||
| 2025-01-31 | Caplan Jay David President, Chief Product Off. | Option exercise 10b5-1 | +22,346 | $1.70 | $38K | 175,890 |
| 2025-01-31 | Caplan Jay David President, Chief Product Off. | Sale 10b5-1 | −22,346 | $1.81 | $40K | 153,544 |
| 2025-01-31 | Caplan Jay David President, Chief Product Off. | Option exercise · Stock Option 10b5-1 | −22,346 | 17,924 | ||
| 2025-01-30 | Rajagopalan Harith Chief Executive Officer | Option exercise 10b5-1 | +20,948 | $1.70 | $36K | 512,277 |
| 2025-01-30 | Rajagopalan Harith Chief Executive Officer | Sale 10b5-1 | −20,948 | $1.95 | $41K | 491,329 |
| 2025-01-30 | Rajagopalan Harith Chief Executive Officer | Option exercise · Stock Option 10b5-1 | −20,948 | 102,536 | ||
| 2025-01-30 | Caplan Jay David President, Chief Product Off. | Option exercise 10b5-1 | +21,472 | $1.70 | $37K | 175,016 |
| 2025-01-30 | Caplan Jay David President, Chief Product Off. | Sale 10b5-1 | −21,472 | $1.95 | $42K | 153,544 |
| 2025-01-30 | Caplan Jay David President, Chief Product Off. | Option exercise · Stock Option 10b5-1 | −21,472 | 40,270 | ||
| 2024-11-11 | Rajagopalan Harith Chief Executive Officer | Sale | −96,517 | $2.47 | $238K | 491,329 |
| 2024-11-11 | Caplan Jay David President, Chief Product Off. | Sale | −64,197 | $2.47 | $159K | 153,544 |
| 2024-11-10 | Rajagopalan Harith Chief Executive Officer | Option exercise | +216,924 | 587,846 | ||
| 2024-11-10 | Rajagopalan Harith Chief Executive Officer | Option exercise · Restricted Stock Units | −216,924 | 0 | ||
| 2024-11-10 | Caplan Jay David President, Chief Product Off. | Option exercise | +187,257 | 217,741 |
Page 3 of 8 · 154 trades